Benitec replaces CFO
This article was originally published in Scrip
Executive Summary
John Rawling, Benitec's chief financial officer and company secretary, will leave the company effective 24 August 2011, after five years' service and four in his current position. Greg West will officially take over as CFO from that date. Benitec, a company working on gene silencing for human therapeutics, is relocating from Melbourne to Sydney, and it is in relation to this that Mr Rawling is leaving the company.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.